It was suggested I copy this post that I made yesterday at another location, so here it is:
Loose Lips Wednesday, 09/21/16 05:23:18 PM
Re: canoma post# 159876
Post #
159905
of 159964 Go
Canoma, your discouragement is understandable when you have a lot of money invested in something which "seems" to be a bad investment. This having been my first biotech investment I am also disappointed that the timetables I had for my money are not the time tables which were realistic for a biotech, but I have also realized that my disappointment is due to my naivete, not due to failures on CTIX's part. Do not let the banter about delays fool you. CTIX has been progressing the drug pipeline within the expected times industry timelines. (see the chart link I am posting below. BK that also answers the question you had for another poster wink.)
Sure, things can go faster, but that is based on factors that are both within and outside of company control. The big one that everyone thinks is 100% in CTIX control is money. I argue that is only partially true. CTIX has demonstrated that they have been able to manage their funds well when it has been in their control. The part out of their control is share price and new investment. The company has/is relying upon share price to execute funding agreements so a result of the targeted takedown, by way of an fallacious article and lawsuits, tanked the value and therefore stalled and increased durations to accomplish the trials. I argue that this type of delay was/is out of the company control, because they are not going to take drastic measures which will hurt the company long term, just to get a potential boost short term. So with less value available in the share price management then focused on how to adjust plans to maximize the speed of progress with pushing forward on the drug(s) which will have the greatest chance of securing that necessary funding through a buyout or partnership. This is where we are at now.
Long story short is, I believe that CTIX has made the best of the circumstances which they have been faced with. They have continued to make actual, meaningful, company progress to bring drugs closer to the point of generating real value in the share price, all the while doing within industry standard timetables. So keep the faith, so to speak, because as soon as a deal is signed for P CTIX will have the funds necessary to accelerate the remainder of the pipeline and us share holders will get those coveted gains we have been patiently waiting for.
https://pbs.twimg.com/media/CselIwzWAAE0AaN.jpg:large
Loose Lips Wednesday, 09/21/16 05:23:18 PM
Re: canoma post# 159876
Post #
159905
of 159964 Go
Canoma, your discouragement is understandable when you have a lot of money invested in something which "seems" to be a bad investment. This having been my first biotech investment I am also disappointed that the timetables I had for my money are not the time tables which were realistic for a biotech, but I have also realized that my disappointment is due to my naivete, not due to failures on CTIX's part. Do not let the banter about delays fool you. CTIX has been progressing the drug pipeline within the expected times industry timelines. (see the chart link I am posting below. BK that also answers the question you had for another poster wink.)
Sure, things can go faster, but that is based on factors that are both within and outside of company control. The big one that everyone thinks is 100% in CTIX control is money. I argue that is only partially true. CTIX has demonstrated that they have been able to manage their funds well when it has been in their control. The part out of their control is share price and new investment. The company has/is relying upon share price to execute funding agreements so a result of the targeted takedown, by way of an fallacious article and lawsuits, tanked the value and therefore stalled and increased durations to accomplish the trials. I argue that this type of delay was/is out of the company control, because they are not going to take drastic measures which will hurt the company long term, just to get a potential boost short term. So with less value available in the share price management then focused on how to adjust plans to maximize the speed of progress with pushing forward on the drug(s) which will have the greatest chance of securing that necessary funding through a buyout or partnership. This is where we are at now.
Long story short is, I believe that CTIX has made the best of the circumstances which they have been faced with. They have continued to make actual, meaningful, company progress to bring drugs closer to the point of generating real value in the share price, all the while doing within industry standard timetables. So keep the faith, so to speak, because as soon as a deal is signed for P CTIX will have the funds necessary to accelerate the remainder of the pipeline and us share holders will get those coveted gains we have been patiently waiting for.
https://pbs.twimg.com/media/CselIwzWAAE0AaN.jpg:large
4
